Mode
Text Size
Log in / Sign up
N/A N=184 Randomized Single-blind Treatment

Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services

Alcoholism · Substance-related Disorders · Dual Diagnosis

Enrolled (actual)
184
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcome: Primary: Standard Ethanol Content Units (SECs) Baseline — 179.9; 190.1 Standard Ethanol Content Unit

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Group Motivational Interviewing (GMI) (Behavioral); Control Treatment Condition (CT) (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Jul 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Standard Ethanol Content Units (SECs) Baseline
179.9; 190.1
PRIMARY
Standard Ethanol Content Units (SECs) at 1 Month
44.9; 36.9
PRIMARY
Standard Ethanol Content Units (SECs) at 3 Months
50.1; 37.7
PRIMARY
Standard Ethanol Content Units (SECs) at 6 Months
96.5; 66.9
PRIMARY
Peak SEC at Baseline
21.0; 19.1
PRIMARY
Peak SEC at 1 Month
4.8; 4.5
PRIMARY
Peak SEC at 3 Months
9.8; 5.9
PRIMARY
Peak SEC at 6 Months
10.3; 7.2
PRIMARY
Alcohol Drink Days at Baseline
13.3; 14.8
PRIMARY
Alcohol Drink Days at 1 Month
4.6; 5.5
PRIMARY
Alcohol Drink Days at 3 Months
6.2; 6.6
PRIMARY
Alcohol Drink Days at 6 Months
8.3; 8.3
PRIMARY
Binge Drink Days at Baseline
11.0; 12.0
PRIMARY
Binge Drink Days at 1 Month
3.0; 3.0
PRIMARY
Binge Drink Days at 3 Months
5.1; 4.0
PRIMARY
Binge Drink Days at 6 Months
6.2; 5.7
PRIMARY
Illicit Drug Use Days at Baseline
6.2; 7.7
PRIMARY
Illicit Drug Use Days at 1 Month
2.2; 1.7
PRIMARY
Illicit Drug Use Days at 3 Months
2.0; 2.5
PRIMARY
Illicit Drug Use Days at 6 Months
3.4; 3.3
PRIMARY
Substance Use Disorder Treatment Sessions at Baseline
3.7; 4.7
PRIMARY
Substance Use Disorder Treatment Sessions at 1 Month
20.9; 22.2
PRIMARY
Substance Use Disorder Treatment Sessions at 3 Months
8.1; 6.3
PRIMARY
Substance Use Disorder Treatment Sessions at 6 Months
3.2; 1.8
PRIMARY
Twelve-Step Sessions Attended at Baseline
5.2; 3.8
PRIMARY
Twelve-Step Sessions Attended at 1 Month
10.7; 10.8
PRIMARY
Twelve-Step Sessions Attended at 3 Months
9.8; 7.5
PRIMARY
Twelve-Step Sessions Attended at 6 Months
6.7; 3.8
PRIMARY
Times Involved in Community Participation Activities at Baseline
10.4; 14
PRIMARY
Times Involved in Community Participation Activities at 1 Month
18.4; 25.2
PRIMARY
Times Involved in Community Participation Activities at 3 Months
16.7; 19.4
PRIMARY
Times Involved in Community Participation Activities at 6 Months
16.7; 14.5
PRIMARY
Days Involved in Productive Work Activities at Baseline
2.2; 3.0
PRIMARY
Days Involved in Productive Work Activities at 1 Month
3.6; 3.5
PRIMARY
Days Involved in Productive Work Activities at 3 Months
7.0; 7.0
PRIMARY
Days Involved in Productive Work Activities at 6 Months
8.0; 9.8
SECONDARY
Mental Health Treatment Sessions at Baseline
0.36; 0.20
SECONDARY
Mental Health Treatment Sessions at 1 Month
0.79; 0.39
SECONDARY
Mental Health Treatment Sessions at 3 Months
1.0; 0.25
SECONDARY
Mental Health Treatment Sessions at 6 Months
0.78; 0.27
SECONDARY
Substance Use Disorder and Mental Health Treatment Sessions at Baseline
4.0; 4.9
SECONDARY
Substance Use Disorder and Mental Health Treatment Sessions at 1 Month
21.7; 22.6
SECONDARY
Substance Use Disorder and Mental Health Treatment Sessions at 3 Months
9.1; 6.5
SECONDARY
Substance Use Disorder and Mental Health Treatment Sessions at 6 Months
4.0; 2.0
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at Baseline for Alcohol Use
0.50; 0.50
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at 1 Month for Alcohol Use
0.18; 0.19
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at 3 Months for Alcohol Use
0.31; 0.27
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at 6 Months for Alcohol Use
0.49; 0.41
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at Baseline for Psychiatric Status
0.47; 0.40
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at 1 Month for Psychiatric Status
0.28; 0.26
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at 3 Month for Psychiatric Status
0.30; 0.26
SECONDARY
Addiction Severity Index-Lite (ASI-Lite) at 6 Months for Psychiatric Status
0.38; 0.30
SECONDARY
Short Inventory of Problems (SIP) at Baseline
27.0; 26.1
SECONDARY
Short Inventory of Problems at 1 Month
6.5; 6.9
SECONDARY
Short Inventory of Problems at 3 Months
9.8; 7.6
SECONDARY
Short Inventory of Problems at 6 Months
11.1; 10.8
SECONDARY
Social Support Survey Total Score at Baseline
61.1; 60.3
SECONDARY
Social Support Survey Total Score at 1 Month
63.3; 68.2
SECONDARY
Social Support Survey Total Score at 3 Months
63.1; 66.8
SECONDARY
Social Support Survey Total Score at 6 Months
61.2; 65.7
SECONDARY
Quality of Life Survey (QOLS) at Baseline
61.6; 68.8
SECONDARY
Quality of Life Survey (QOLS) at 1 Month
71.2; 73.5
SECONDARY
Quality of Life Survey (QOLS) at 3 Months
72.4; 75.1
SECONDARY
Quality of Life Survey (QOLS) at 6 Months
71.3; 72.6
SECONDARY
Brief Symptom Inventory (BSI-18) at Baseline
21.4; 19.3
SECONDARY
Brief Symptom Inventory(BSI-18) at 1 Month
15.9; 14.2
SECONDARY
Brief Symptom Inventory (BSI-18) at 3 Months
16.1; 13.1
SECONDARY
Brief Symptom Inventory (BSI-18) at 6 Months
17.2; 15.9
SECONDARY
SF-12 Health Survey Physical Summary Score at Baseline
41.6; 41.6
SECONDARY
SF-12 Health Survey Physical Summary Score at 1 Month
40.2; 43.6
SECONDARY
SF-12 Health Survey Physical Summary Score at 3 Months
41.0; 42.2
SECONDARY
SF-12 Health Survey Physical Summary Score at 6 Months
40.4; 40.8
SECONDARY
SF-12 Health Survey Mental Summary Score at Baseline
35.9; 39.0
SECONDARY
SF-12 Health Survey Mental Summary Score at 1 Month
43.9; 44.5
SECONDARY
SF-12 Health Survey Mental Summary Score at 3 Months
43.0; 44.7
SECONDARY
SF-12 Health Survey Mental Summary Score at 6 Months
42.7; 44.6
SECONDARY
Treatment Motivation Questionnaire (TMQ) at Baseline
2.4; 2.6; 6.1; 6.0
SECONDARY
Treatment Motivation Questionnaire (TMQ) at 1-month
2.2; 2.6; 5.8; 5.8
SECONDARY
Treatment Motivation Questionnaire (TMQ) at 3-month
2; 2.5; 5.4; 5.6
SECONDARY
Treatment Motivation Questionnaire (TMQ) at 6-months
2.2; 2.5; 5.5; 5.3
SECONDARY
Fagerstrom Test for Nicotine Dependence at Baseline
4.5; 4.0
SECONDARY
Psychiatric Outpatient Satisfaction Scale - Total Score
61.1; 60.1
SECONDARY
Helping Alliance Questionnaire - Total Score
100.1; 101.6

Summary

Homeless Veterans with substance use disorders (SUDs) are a major group served by VA and are heavily represented in VA housing. VA recently adopted a 'Housing First' approach emphasizing rapid housing placement to initiate recovery without requiring sobriety and will necessitate SUD interventions that are efficient and easily layered onto existing services. The proposed study will investigate the effectiveness, implementation process, and cost estimate of Group Motivational Interviewing (GMI) for Veterans with SUDs in VA housing (Housing Urban Development-VA Support Housing [HUD-VASH] and Grant and per Diem [GPD]). Outcomes will be assessed at multiple time points using a multi-modal approach. The ultimate goal of this research is to establish the basis of a GMI dissemination and implementation course of action for highly vulnerable homeless Veterans in VA housing for achieving their greatest success in attaining housing stability.

Eligibility Criteria

Inclusion Criteria

  • Men and women Veterans currently in Housing Urban Development-VA Support Housing [HUD-VASH] and Grant and per Diem [GPD]), newly entering the program but not yet housed, or Veterans on the HUD-VASH interest (wait) list.
  • Able to comprehend English.
  • Meets DSM-V criteria for a current substance use disorder and have used substances in the 30 days prior to treatment entry. Participants on medications targeting their substance use must be stabilized on medications for at least 2 weeks before therapy initiation.
  • May meet criteria a mood, anxiety or other psychiatric disorder. Participants on maintenance medications for a mood or anxiety disorder must be stabilized on medications for at least 2 weeks before therapy initiation.
  • Able to adequately provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments.
  • Willing to commit to 4 group therapy sessions, baseline, 1, 3, and 6 month follow-up assessments.

Exclusion Criteria

  • Active suicidal or homicidal ideation with a plan as this is likely to require hospitalization or other interventions that could interfere with study participation.
  • Unstable psychiatric condition that is likely to require hospitalization or other interventions that would interfere with study participation.
  • Unstable medical condition or one that may require hospitalization during the course of the study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02233738). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search